Tumor-derived Prevotella intermedia aggravates gastric cancer by enhancing Perilipin 3 expression

Wei Liang1,2, Zhengyang Zhou3, Qizhao Gao1

  • 1Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Cancer Science
|January 30, 2024
PubMed

Insights

Prevotella intermedia bacteria in gastric cancer (GC) tissues promote tumor growth and invasion. This bacterium influences GC progression by altering perilipin 3 (PLIN3) expression, suggesting it could be a diagnostic and prognostic biomarker.

Area of Science:

  • Microbiology
  • Oncology
  • Molecular Biology

Background:

  • The tumor microenvironment, including indigenous microbes, significantly impacts gastric cancer (GC) development.
  • Prevotella intermedia (P. intermedia) is implicated in GC pathogenesis, but its precise roles and mechanisms require elucidation.

Purpose of the Study:

  • To investigate the functional roles and molecular mechanisms of P. intermedia in the malignant progression of GC.
  • To assess the potential of P. intermedia abundance as a biomarker for GC diagnosis and prognosis.

Main Methods:

  • Isolation and quantification of P. intermedia from GC tissues using quantitative real-time PCR (qRT-PCR).
  • Assessing the effects of P. intermedia supernatant on GC cell proliferation, migration, and invasion.
  • Analyzing protein expression changes in GC cells co-cultured with P. intermedia via label-free proteomics.
  • Investigating the role of perilipin 3 (PLIN3) using shRNA knockdown.

Main Results:

  • P. intermedia was significantly more abundant in GC tumor tissues than in healthy tissues.
  • Increased P. intermedia abundance correlated with poorer tumor differentiation, invasion, and reduced patient survival.
  • P. intermedia supernatant enhanced GC cell proliferation, migration, and invasion.
  • P. intermedia altered the expression of 34 proteins in GC cells, including PLIN3, and PLIN3 knockdown reversed P. intermedia-induced malignancy.

Conclusions:

  • P. intermedia promotes GC malignant progression through PLIN3 modulation within the tumor microenvironment.
  • P. intermedia abundance may serve as a potential biomarker for GC diagnosis and prognosis.